| 产品详情 |
| Edit |   |
|---|
| Product Name | Human EGFL7 Recombinant |
|---|
| Description | MW: 29,618 Da. Purity >90%, as determined by SDS-PAGE. EGFL7 is an 30 kDa secreted protein that contain an Emilin-like (EMI) domain, and 2 epidermal growth factor (EGF) domains, one of which binds calcium. Based on these domains, it has been hypothesized that EGFL7 may self-assemble like extracellular matrix (ECM) proteins and, thus, could incorporate into ECM. EGFL7 has been reported to stimulate cell adhesion as well as motility in a manner similar to ECM proteins. EGFL7 has been shown to be p |
|---|
| Size | 0.005 mg, 0.025 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [ve-statin; EGFL7] |
|---|
| Gene, Accession, CAS # | EGFL, Gene ID: 51162, Accession: NP_057299.1 |
|---|
| Catalog # | MBS553252 |
|---|
| Price | |
|---|
| Order / More Info | Human EGFL7 Recombinant from MYBIOSOURCE INC. |
|---|
| Product Specific References | • EGFL7: a unique angiogenic signaling factor in vascular development and disease .Blood, Dec 2011; 10.1182/blood-2011-10-322446. • EGFL7 promotes tumor escape from immunity by repressing endothelial cell activation .Cancer Res., Dec 2011; 71: 7176 - 7186. • gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis related genes acvrl1 and EGFL7 in early-onset disease .Mol. Hum. Reprod., Oct 2011; 10.1093/molehr |
|---|
| 产品资料 |
|
|